is not clear whether it replicates there. A precondition for replication should be the formation of covalently closed viral DNA and transcription of all essential viral mRNAs. The mRNAs of HBV form a nested box with common 3 ends. In order to detect even low levels of potential replication, we developed a quantitative reverse transcription-PCR method for detection of a smaller HBV mRNA species in the presence of the larger ones. All three highly viremic patients tested so far had mRNAs for the large and the small surface proteins and the X protein of the virus within PBMC but not in the virus from their sera. Furthermore, we detected by PCR covalently closed viral DNA in their PBMC. These data suggest that HBV may be not only taken up but also replicated by mononuclear blood cells and that these cells may be an extrahepatic site of viral persistence. X mRNA was detected in the largest amount. Possibly, X protein interferes with functions of the mononuclear cells during the immune response against the virus.
Hepatitis B virus (HBV) and other hepadnaviruses are generally considered to be highly hepatotropic. Nevertheless, small amounts of HBV-specific nucleic acids can be detected in many extrahepatic tissues during acute and chronic infection (3, 5, 8, 11-14, 21, 29, 32, 37, 39, 45, 46, 54, 55) . Furthermore, there is evidence of extrahepatic HBV persistence in HBV carriers after liver transplantation (20, 21, 33, 35, 36, 38, 44, 56, 64) . A better understanding of HBV latency after liver transplantation is of high clinical relevance. Several authors have used peripheral blood mononuclear cells (PBMC) to study HBV infection in nonhepatic tissues because PBMC are easily available. Moreover, infection of these cells by HBV could interfere with the host's immune defense against the virus and support the establishment of HBV persistence (22, 23) . Adsorption of HBV to PBMC seems to be a receptor-mediated process (23, 24, 43, 46) . Whether further steps of HBV replication, such as internalization, uncoating, and genome complementation to a double-stranded covalently closed circular DNA (cccDNA) molecule, can be supported by human nonhepatocytes is still a subject of controversy (29) . As the expression of viral genes in a host cell is a basic requirement for the replication of any virus, it should be possible to detect HBV mRNAs in those cells if, indeed, HBV replication takes place. Detection and characterization of HBV gene expression in nonhepatocytes, however, are difficult for several reasons. First, the amount of HBV-specific nucleic acids and the number of infected cells to be expected are very low compared to those for hepatocytes infected with the virus. Second, it is difficult to discriminate between newly synthesized HBV DNA or RNA and virus-specific nucleic acids simply originating from viral particles adsorbed to the cell surface. To obtain a sufficient sensitivity, PCR has been applied in several studies. This technique allows detection of the HBV DNA genome or its RNA transcripts in general (3, 5, 21, 39, 45) . However, to date knowledge about the transcriptional pattern of HBV in nonhepatocytes is incomplete, because it is difficult to distinguish the four known mRNA species of HBV by conventional reverse transcription-PCR (RT-PCR). Those studies are complicated by replicative RNA containing intermediates generated during the replication cycle and by the coterminal nature of the HBV RNA transcripts. The complete sequence of each of the four HBV RNA transcripts designated X (0.65 kb), S (2.1 kb), pre-S (2.4 kb), and C-E or pregenome (3.5 kb) is also found at the 3Ј terminus of the next larger one (42, 59, 62) . It is well established that the C-E, pre-S, and S transcripts are essential for HBV replication (42) . The necessity for X mRNA and X protein is not yet known. They may be dispensable in HBV-transfected cells (9) . In transgenic mice, the X gene seems to be relevant for the expression of HBV genes in the liver but not in other tissues (41) . The HBV X gene product may transactivate a broad variety of other genes, including HLA genes (26) and genes coding for cytokines, possibly by interacting with cellular transcription factors (57) . Whatever the function of X protein may be, it would be interesting to know whether its mRNA is expressed in PBMC from HBV carriers. We have devised a differential PCR protocol, designated paired comparative PCR (pcPCR), which allows quantitation and distinction of the four major HBV mRNAs in PBMC from chronic HBV carriers, and we have confirmed its validity by use of numerous controls. In addition, we applied a highly sensitive PCR approach to discriminate between the HBV relaxed circular DNA (rcDNA) genome present in virions and the cccDNA generated by the DNA repair machinery of the host cell nucleus. The rcDNA form of the circular HBV genome of about 3.2 kb is only partially double stranded, and neither the plus strand nor the minus strand is covalently closed. Due to its structure, it cannot directly serve as a matrix for RNA transcription. Generation of cccDNA is essential for HBV gene expression and replication. Therefore, detection of cccDNA in a host cell indicates that the first steps of virus replication took place (25, 29, 42, 63) .
MATERIALS AND METHODS
Clinical samples. PBMC and sera were obtained from three patients, age 12, 21, and 22 years. They all had been infected with HBV in an endemic outbreak at the oncology unit of the Children's University Hospital, Giessen, Germany, from 1984 to 1986 while undergoing multidrug anticancer chemotherapy for leukemia or other malignant diseases (6) . A patient-to-patient transmission of the virus had been demonstrated (51) . All sera of the three patients included in the present study were positive for hepatitis B surface antigen, hepatitis B e antigen, and HBV DNA. HBV DNA titers were persistently higher than 10 9 genomes/ml of serum. Liver biopsies had revealed a normal histology or at most a minimal hepatitis with some ground-glass hepatocytes but no signs of inflammation. Furthermore, clinical signs of hepatitis or significant elevation of the liver enzymes were never detected in these patients, although they were examined carefully in accordance with the guidelines of the cancer therapy protocols (52, 53) .
Preparation of cells and HBV particles. PBMC were harvested from heparinized whole blood by centrifugation over a Ficoll-Hypaque (Fresenius, Bad-Homburg, Germany) gradient. The mononuclear nonadherent cell fractions from two patients were further enriched for B cells or T cells by positive selection with magnetic beads (Dynabeads M-450; Dynal, Hamburg, Germany) coated with monoclonal mouse anti-CD 19 or mouse anti-CD 2, respectively, according to the manufacturer's recommendations. For harvesting of HBV particles, 1 ml of the patients' sera was diluted with 3 ml of phosphate-buffered saline and subjected to ultracentrifugation through a cushion of 0.5 ml of 10% sucrose (Beckman SW60Ti rotor; 2 h, 4°C, 50,000 rpm) (49) . The pellets were dissolved in 20 l of sterile water. Prior to the purification of DNA or RNA, 10 l of the resuspended virus was added to 10 7 PBMC from HBV-negative donors in order to use the cellular nucleic acids as a carrier during the purification and precipitation steps. Pure PBMC from HBV-negative donors were included in each experiment as a negative control.
Purification of RNA and synthesis of cDNA. Poly(A) ϩ RNA was purified by using the Quick Prep mRNA purification kit (Pharmacia, Freiburg, Germany) according to the manufacturer's guidelines. The RNA pellet corresponding to 10 6 cells (for B cells and T cells) or 10 7 cells (for whole PBMC preparations) was dissolved in 15 l of sterile water containing RNasin (Promega, Madison, Wis.) at 1 U/l. Seven microliters of different dilutions was subjected to RT. After denaturation of the RNA at 70°C for 5 min, the cDNA synthesis was carried out at 37°C for 60 min in a total volume of 20 l with 100 pmol of random hexamer primers (Boehringer, Mannheim, Germany) and 200 U of Moloney murine leukemia virus reverse transcriptase (Gibco/BRL, Paislay, United Kingdom) as described previously (10) .
DNA extraction. Approximately 10 6 B cells, 10 6 T cells, or 10 7 PBMC, as well as mixtures of 10 5 sucrose-gradient purified HBV particles with PBMC from HBV-negative individuals, were suspended in 1 ml of 50 mM MOPS [3-(Nmorpholino)-propanesulfonic acid] (Sigma, Deisenhofen, Germany) buffer, pH 7.0. The samples were treated with proteinase K in the presence of sodium dodecyl sulfate as previously described (49) . HBV DNA was purified by ionexchange chromatography with a Quiagen 20 column (Diagen, Düsseldorf, Germany) according to the manufacturer's protocol (19) . Magnetic beads were removed from B-cell or T-cell preparations by trapping them in a magnetic field. Before removal of sodium dodecyl sulfate by precipitation with potassium acetate and loading the samples onto the column, the chromosomal DNA was sheared by passing the sample fluid 20 times through a 20-gauge needle. Finally, the DNA pellet was dissolved in sterile water at a concentration of 80 ng/l. Digestion of DNA with mung bean nuclease for detection of cccDNA. Ten microliters of PBMC DNA (800 ng) was dissolved in sterile double-distilled water and added to 10 l of a reaction mixture containing 20 U of mung bean nuclease (Calbiochem, Bad-Soden, Germany) in 2 mM ZnCl 2 -100 mM Na acetate (pH 5.0)-60 mM NaCl according to a previously published procedure (34) with some modifications. After incubation at 37°C for 30 min, the reaction was stopped with 2.5 l of EGTA (100 mM, pH 7.4). Five microliters was used as the template during the first round of nested PCR as described below for detection of cccDNA.
PCR primer selection. PCR primers purified by reverse-phase high-performance liquid chromatography were purchased commercially (Roth, Karlsruhe, Germany). Primer sequences were chosen according to the sequence of the HBV isolate which had infected all three patients (EMBL accession number Y07587). Compared to this sequence, the HBV subtype ayw published by Bichko et al. (7) had the highest homology (98.7%) among all other HBV sequences published to date. The presence of an identical HBV nucleotide sequence in all patients was an important precondition of this study, because variations at the PCR primer binding regions could cause false-negative results or reduce amplification efficiencies. The primer sequences are shown in Table 1 . Their positions in the HBV genome and in the four RNA transcripts are shown schematically in Fig. 1 . Primers P1 to P16 were used to determine the expression of the different HBV RNA molecules. The sequence included in primers P1 to P4 is present in all four RNA transcripts of the virus. This primer set was designated X ( Fig. 1 and Table  1 ) because it is the only one to anneal with sequences of the X mRNA of 0.65 kb. Primers P5 to P8 cannot anneal with the X mRNA but can anneal with any of the three larger ones. This set was designated S. Primers P9 to P12 (designated pre-S) should reveal a PCR product only if the two groups of largest HBV RNA transcripts, of about 2.4 and 3.5 kb, are present in the sample. Finally, P13 to P16 are specific for the 3.5-kb HBV RNAs, which serve as an RNA pregenome during replication of the HBV genome, as mRNA for the hepatitis B core and the viral polymerase, and for synthesis of the e protein (42) . This set of primers was named C-E. For pcPCR two primer pairs covering a different number of HBV mRNA classes were applied together in the same reaction tube. For example, set X (P1 to P4), covering all four mRNAs, was used together with set S (P5 to P9), covering three mRNAs. Primers P17 to P20 (designated S-3Ј) were applied in a control reaction to detect possible artifacts due to different distances between the positions of the PCR primer sets and the ends of the mRNA molecules. Theoretically, longer distances between the RNA 3Ј ends and the PCR primer positions might improve the efficacy of random priming by providing more space for random hexamer nucleotides to bind and initiate cDNA synthesis. The distance between the PCR primer positions and the mRNA 5Ј ends might become relevant if partial digestion by exonucleases occurred. To check these possibilities, primers P5 to P8 (set S) were used together with primers P17 to P20 (set S-3Ј). Both sets of primers are able to detect all HBV RNAs except the smallest one. However, primers of set S-3Ј are located at a central region of the 2.1-kb RNA about 600 nucleotides closer to its 3Ј end than primers of set S. Provided that pcPCR is not affected by the different locations of these primer sets, PCR products should be generated in a ratio of 1 to 1 if set S and set S-3 are used together.
Primers P23 to P26 were selected to discriminate between the rcDNA genome of HBV particles and HBV cccDNA present in the nuclei of infected host cells, as previously described (34) . HBV rcDNA contains two regions sensitive to digestion with mung bean nuclease: the single-stranded area, which covers about 10 to 60% of the genome length, and a nick within the minus strand around position 1820. Sense primers P23 and P25 are located within the single-stranded region of HBV rcDNA. If they are used together with the antisense primers P24 and P26, amplification runs across the minus-strand nick of HBV rcDNA in both rounds of nested PCR. After digestion of the PCR templates with mung bean nuclease, a positive signal should be obtained only from HBV cccDNA present in cells supporting HBV replication and not from rcDNA originating from viral particles ( Table 1 and Fig. 1 ).
PCR amplification. pcPCR was carried out with a nested PCR protocol to improve sensitivity and specificity. A hot start was not performed because HBV particles contain an incomplete DNA plus strand. During heating to 94°C at the first cycle, Taq polymerase elongates this strand. Variable lengths of singlestranded regions of the HBV genome otherwise might compromise pcPCR with DNA samples. During the first round of nested PCR, 30 amplification cycles of 105 s at 94°C, 90 s at 60°C, and 90 s at 72°C (with a 3-s extension per cycle, except for 10 min during the last cycle) were carried out in a 50-l final volume containing 4 pmol of each primer. One microliter of the first-round product was subjected to the second round. It differed from the first round by the number of cycles, which was reduced to 20, and the amounts of primers (20 pmol each). PCR cycling was performed in a Bio-Med Thermocycler 60 (Bio-Med, Theres, Germany) with a GeneAmp kit (Perkin-Elmer, Ü berlingen, Germany). The products of pcPCR were subjected to quantitative post-PCR analysis with the GENESCAN 672 software on an Applied Biosystems model 373A Automated DNA Sequencer (Perkin-Elmer/Applied Biosystems Division [PE/ABI], Foster City, Calif.).
For detection of cccDNA, a modified nested PCR assay was performed. Samples were overlaid with a drop of mineral oil (Sigma, St. Louis, Mo.) before addition of the templates. After an initial melting step of 3 min at 94°C, 35 cycles (first round) or 30 cycles (second round) of 1 min at 94°C, 1 min at 60°C, and 1 min at 73°C were carried out. During the final cycle, the extension step was prolonged to 5 min. Two microliters of the first-round product was used as the template for the second round of PCR. During the first PCR round, the MgCl 2 concentration was increased from 1.5 to 4 mM. The amounts of PCR primers were 10 pmol each in both rounds. All other conditions remained as described for pcPCR. GENESCAN analysis. One microliter of the second-round products of nested pcPCR was subjected to automatic fluorescence-based post-PCR analysis as described previously (48) . Quantitative analysis by calculation of the peak area corresponding to each of the two products of a pcPCR was performed with an Apple MacIntosh IIci computer with the GENESCAN 672 software (ABI/PE). Analysis was carried out within the linear range of the system, which covers 3 orders of magnitude.
RESULTS

pcPCR.
Only the largest transcript, which encodes hepatitis B core or e protein and the viral polymerase, can be determined directly by RT-PCR because it contains a sequence at its 5Ј end which is not present in the smaller HBV mRNAs (50) .
To study the presence of the smaller HBV RNAs, we have developed a quantitative assay based on comparative RT-PCR. Assuming that all four HBV mRNAs are transcribed in an infected cell, the nucleotide sequence of the smallest tran-script, which is also present at the 3Ј terminus of all of the other ones, should give rise to the largest amount of amplification product. The nucleotide sequence present in only three of the mRNAs should lead to the second-highest amount of PCR product, and so on. Based on these considerations, a primer set covering n classes of HBV mRNAs and another primer set covering n ϩ 1 classes of mRNAs were applied together in a single pcPCR tube. For example, set S was used together with set X ( Fig. 1 and Table 1 ). The amount of PCR product generated by each set of primers was calculated quantitatively by integration of the fluorescent light signal for the amplification product in the GENESCAN evaluation. Figure 2 shows a graphical display of the pcPCR results from PBMC from patient 1. The value obtained with the primer set covering the RNA of interest and, implicitly, all of the larger HBV RNA species (n ϩ 1), was divided by the value obtained with the simultaneously applied primer set covering only the larger HBV mRNAs (n) ( Table 2) , and the results were displayed on a semilogarithmic scale ( Fig. 3) . A ratio significantly greater than 1 indicates that the RNA of interest was present in the reaction tube.
However, variations of this ratio due to methodological instabilities also have to be considered. Thus, we first examined which ratios were generated by pcPCR if preparations containing only PBMC DNA were tested. Furthermore, HBV DNA or HBV RNA from virus particles was analyzed. The 15 determinations with primer sets X-S, S-pre-S, and pre-S-C-E with PBMC DNA as a template yielded values of between 0.72 and 1.27 ( Table 2 ). The arithmetic mean value Ϯ standard deviation (SD) was 1.01 Ϯ 0.14. The mean values for HBV DNA from cell extracts (1.01) and from virus particles (1.05) were not significantly different, suggesting that the cells did not contain large proportions of 5Ј-or 3Ј-terminal subgenomic DNA fragments. Furthermore, the data showed that pcPCR is a relatively precise method. The highest value for the upper limit of the 95% confidence interval for a ratio generated by samples which should contain all PCR target sequences in equal amounts (PBMC DNA, virion DNA, virion RNA, or pcPCR with primer set S-S-3Ј) was 1.43. Thus, ratios higher than 1.43 are indicative of the existence of a smaller mRNA detected by only one pair of pcPCR primers together with larger ones detected by both sets of primers ( Fig. 3) .
Validation by analysis of HBV poly(A) ϩ RNA preparations derived from viral particles from the same patients is of further relevance for discrimination between intracellular de novo synthesis of HBV nucleic acids and specific nucleic acids derived a Primers of the same polarity as HBV mRNAs are sense primers. Nucleotide positions are numbered in the sense direction according to the sequence with EMBL accession number Y07587. As the unique EcoRI restriction site found in most HBV subtypes is not present in this sequence, numbering starts at the homologous site. In the last column the size of the second-round product of each nested PCR set is given. Primers carrying the fluorescent dye FAM (6-carboxy-fluorescein) at their 5Ј ends to generate labelled fragments for quantitative post-PCR analysis are in boldface. Primers P1 to P16 were used to determine the expression of the four different HBV-RNA transcripts. P1-P2, P5-P6, P9-P10, and P13-P14 were applied in the first round, and the other ones were applied in the nested PCR. Primers P17 to P20 were applied in a control reaction. Primers P21 and P22 were combined with P1 and P3, respectively, in order to detect any multimers of the pregenomic HBV RNA. Primers P23 to P26 were applied in a nested PCR to detect cccDNA of HBV. Primer combinations P27-P28 and P29-P28 were applied in a long-PCR protocol to generate DNA templates for construction of the two RNA standards sS (1,914 bp) and sX (752 bp) by in vitro transcription (47) . The SP6 promoter sequences are underlined. At the 5Ј end of P28 there is an oligod(T) 17-mer to create a poly(A) tail at the 3Ј ends of the RNA standards. from adsorbed or phagocytosed virions. Because the encapsidation signal of the RNA pregenome is at its 5Ј end (28) and poly(A) ϩ RNA was analyzed, only full-length or spliced RNA molecules should be in the virion extracts. The mean value (Ϯ SD) of the GENESCAN assay ( Table 2 ) was 1.15 Ϯ 0.14. This result shows that smaller RNAs were not present in detectable amounts. Spliced pregenomes or DNA derived from them would lead to values different from 1 if a primer binding site was affected. A mean value of 1.15 is not significantly higher than the one for HBV DNA. Except for two determinations, all pcPCR ratios obtained for mRNAs from PBMC, B cells, or T cells were significantly higher (P Ͼ 95%). However, the existence of X mRNA in T cells from patient 3 and the existence of pre-S RNA in T cells from patient 2 could not be proven. Figure 3 shows a graphical display of the results of pcPCR. The poly(A) ϩ RNA extract from serum-derived viral particles and all cellular poly(A) ϩ RNA extracts contained C-E sequences. The ratio of pre-S RNA to C-E RNA was relatively high in B cells and total PBMC (4.4 to 5.1) and lower in T cells (1.4 and 2.6). While the C-E RNA could be derived from adherent or ingested virions, the pre-S RNA had to be generated by de novo transcription. The ratio for pre-S to S RNA was again very high in total PBMC from patient 1 (11.1) and in B cells (6.0 and 3.5) and was lower but still well above 1 in T cells (4.1 and 2.9). The lowest ratios were found for the X to S RNAs. The PBMC from patient 1 and the B cells from patients 2 and 3 had still easily detectable amounts of short X RNA, while the result was borderline with T cells from patient 2 and was not significantly higher than 1 for T cells from patient 3. This does not mean that X mRNA is present at the lowest concentrations, because the fractions multiply from the largest RNA pair to the smaller pairs. One molecule of C-E RNA from PBMC from patient 1 would theoretically be accompanied by about 4 molecules of pre-S RNA, 44 molecules of S RNA, and 123 molecules of X RNA ( Table 2) .
Absence of multimeric molecules of the HBV RNA pregenome. HBV RNA molecules of 7.5 kb, possibly transcribed from multimeric HBV DNA molecules, have been observed in PBMC from experimentally infected chimpanzees (31) . In order to detect this species of molecules, a different nested PCR was carried out. During the first round, primers P1 and P21 were applied, and P3 and P22 were used during the second round. However, no PCR product could be obtained with these FIG. 1. Schematic diagram of the positions of the PCR primers. The shaded areas indicate the regions spanned by the PCR primer sets X, S, pre-S, C-E, and S-3Ј, in accordance with the different kinds of HBV RNA transcripts. The scattered area represents the part of the circular HBV genome spanned by primers P23 to P26. These primers were applied in a nested PCR protocol after digestion of the sample DNA with mung bean nuclease to discriminate between the relaxed circular form (rcDNA) and the covalently closed circular form (cccDNA) of the HBV genome. The sequences of the PCR primers grouped in these six sets are shown in Table 1 . a pcPCR was carried out with four different combinations of PCR primer sets. The samples containing nucleic acid preparations from total PBMC, B cells, T cells, or HBV particles were obtained from three patients. For each sample, preparations of poly(A) ϩ RNA as well as total DNA were analyzed. The amount of PCR product generated by each of the two PCR primer sets applied simultaneously for comparative PCR was calculated quantitatively by using the GE-NESCAN 672 software (PE/ABI).
b Ratio of the amounts of the two different PCR products generated by each comparative PCR. The amounts of PCR product were calculated on the basis of peak areas, which is more reliable than the use of peak heights. The peak heights, however, represent the results as displayed on the computer screen. The ratios of product generated by each of the two primer sets applied in a pcPCR are clearly different from 1:1 in the case of mRNA templates but not in the case of DNA templates from the patient's PBMC.
primer combinations, suggesting that multimers of the HBV pregenome did not serve as templates in our pcPCR assays (data not shown).
Assessing the sensitivity of nested pcPCR. The sensitivity of our nested PCR protocol for detection of cccDNA was determined by endpoint dilution series with DNA preparations of plasmids containing a full-length HBV genome (pKSVHBV1) (61). The sensitivity was higher than six target molecules per sample. In the case of covalently closed plasmid DNA, there was no change in the level of sensitivity if the samples were treated with mung bean nuclease prior to PCR (Fig. 4B) .
In order to determine the sensitivity of HBV RT-pcPCR, we constructed two RNA standards of 1,914 and 752 bp by solidphase in vitro transcription (47) . Additionally, the transcripts were purified by oligo(dT) affinity chromatography in order to obtain highly pure RNA standards of full length. By using a template of cloned HBV DNA, primers P27 and P28 were applied in a long-PCR protocol (GeneAmp XL PCR kit; Perkin-Elmer) to amplify a DNA fragment for transcription of a 752-kb RNA. This RNA was designated sX. It provided a target sequence for the X pcPCR primer set only, similar to the X mRNA of HBV. In the same way, a 1,914-bp synthetic RNA, designated sS, was transcribed from a long-PCR product obtained with primers P29 and P28. It provided target sequences for the X primer set and for the S primer set, similar to the 2.1-kb mRNA of HBV. It was not possible to copy the sizes of both HBV mRNAs exactly. The 3Ј ends of the PCR primers used to create templates for in vitro transcription had to be placed in nonrepetitive regions of the HBV genome because they otherwise generated additional smaller fragments due to their large size caused by non-HBV sequences at their 5Ј ends [SP6 promoter and oligo(dT) 17-mer]. Both standard RNAs were serially diluted over 14 log steps and put together in a molar ratio of 5 (sX) to 1 (sS). As a template for RT-pcPCR, we used an aliquot from each dilution step together with carrier mRNA from 10 6 HBV-negative PBMC. Over 11 log steps, both templates revealed a positive PCR result. The mean ratio of sS to sX RNA was 4.3. The SD of Ϯ3.3 was higher than was observed in the other control experiments mentioned above. This might be due to additional pipetting steps and a high susceptibility to RNA degradation before the diluted RNA Table 2) . RNA:S/S-3Ј represents a control reaction done to ensure that the results of pcPCR were not affected by different distances between the primer positions and the 5Ј or 3Ј ends of the HBV mRNAs (Fig. 1) .
FIG. 4. Determination of the sensitivity of RT-pcPCR (A) and of nested PCR for detection of cccDNA (B). (A)
To determine the sensitivity of RT-pcPCR, two RNA standards were constructed (47) . Standard RNA sX of 752 bp provided a target sequence for the X primer set (Table 1) , similar to the 0.65-kb mRNA of HBV. The other standard RNA, designated sS, provided target sequences for two primer sets applied in pcPCR (X and S), similar to the 2.1-kb mRNA of HBV. After preparation of a serial dilution over 14 log steps from both standard RNAs, they were mixed in a ratio of 5 (sX) to 1 (sS), as shown at the bottom. An aliquot of each dilution step was added to carrier mRNA from 10 6 HBV-negative PBMC, and RT-pcPCR was performed. The ratios between the peak areas of the two pcPCR products were determined, as shown at the top. It was still possible to detect 200 molecules of standard RNA. (B) The sensitivity of the PCR assay for detection of cccDNA was determined with a serial dilution series of plasmid DNA containing a full-length HBV genome added to 800 ng of carrier DNA from HBV-negative PBMC. The sensitivity of nested PCR was higher than 6 genomes per assay. Addition of mung bean nuclease did not alter the sensitivity, suggesting that cccDNA was not affected by this enzyme under the conditions we used. Comparison of these results to the ones obtained for viral particles (Fig. 5B, lane Vϩ) indicates a difference of at least 5 log steps between viral particle-derived DNA and cccDNA with regard to sensitivity of nested PCR after incubation with mung bean nuclease. standards were added to carrier mRNA. However, the amount of template generated by the sX RNA was always significantly larger than that generated by the sS RNA, even at very high template concentrations, when the PCR was driven extensively into the plateau phase. The sensitivity of RT-pcPCR was higher than 200 RNA molecules per PCR sample, corresponding to 1 mRNA molecule per 1,000 cells (Fig. 4A) .
Further validation of pcPCR. In addition to the control experiments described above, the poly(A) ϩ RNA preparations from our patients' PBMC were subjected to pcPCR with two beta-actin-specific nested primer sets. In order to rule out any impairment by possible DNA contaminations, both sets of primers were chosen to be intron spanning, which was not possible in the case of HBV. Similar to the HBV primers for pcPCR, the positions of the sets were about 800 bp apart from each other. In six pcPCR assays the ratios of PCR products generated by the two sets of primers were in the range of 0.8 to 1.3 (data not shown). These results fit well to the ratio of 1 to be expected theoretically, as both sets of beta-actin primers should bind to each molecule of beta-actin mRNA or cDNA.
Detection of cccDNA in PBMC. PBMC from two patients were assayed for the presence of cccDNA (Fig. 5 ). In samples from patient 2, there was a positive signal in six of six repeated tests. For the PBMC from patient 3, a positive signal was obtained in only three of six tests, suggesting that the amount of cccDNA was close to the detection limit of the assay. To rule out possible artifacts, several controls were included. PBMC from HBV-negative persons were always negative in six tests. DNA from HBV particles gave a faint signal at 297 bp in six tests performed, which corresponds to the expected length of a PCR fragment primed by P25 and P26 during the second round of nested PCR, but no signal at all was seen after treatment with mung bean nuclease (Fig. 5B) . After the first round of nested PCR, a positive signal at the expected length of 449 bp was seen only in the positive control with 10 ng of a plasmid preparation (pKSVHBV1) containing a full-length HBV genome ( Fig. 5A) (61) . Southern blotting of the firstround PCR products and hybridization with a 32 P-labelled HBV DNA fragment (positions 1553 to 1846 of the HBV genome) revealed the following results (Fig. 5C ). The PBMC samples from patient 2, which had revealed strong signals after the second round of PCR, also showed a positive although faint signal at the expected length of 449 bp. In contrast, DNA from HBV particles showed two very strong signals below 449 bp. Very likely they are due to a linear DNA amplification initiated by the two PCR primers but stopping at the 3Ј ends of both strands after opening of HBV rcDNA at 94°C during the PCR melting step. These templates can give rise to product sizes of about 390 and 300 bp, respectively (Fig. 5C ).
DISCUSSION
This report describes the detection of different HBV mRNA transcripts in PBMC from highly viremic carriers. The validity of the data relies on a new, sensitive approach designated pcPCR. pcPCR may be considered a modification of competitive multiplex fluorescent PCR, which already has been successfully used to determine the relative levels of multiple mRNA species simultaneously (67) . Application of such an approach to quantitation of HBV transcripts required further validation, due to the coterminal structures of the different mRNAs and the generation of DNA-RNA hybrids by the unique replication cycle of hepadnaviruses. An undesirable selection of 3Ј-terminal RNA fragments by oligo(dT) separation and loss of the 5Ј-terminal fragments, or variable efficiencies of cDNA priming with regard to the positions of the pcPCR primers on the target RNA molecules, had to be considered as a possible source of artifacts. The validity of our pcPCR assay relies on the following control experiments. First, DNA templates derived from PBMC or HBV particles revealed identical ratios of PCR products, close to 1, irrespective of which primer sets were used for pcPCR. Thus, the efficiency of PCR amplification did not significantly differ between the sets of primers applied. Second, poly(A) ϩ RNA preparations from HBV particles gave pcPCR results very similar to those for DNA templates, again without significant differences in the amounts of product generated by the different primer sets. This result suggests that some viral particles contain nontranscribed RNA pregenomes, as reported by other authors (29) . However, our experiments do not definitively confirm this con- clusion, because positive PCR results may have been caused by traces of virion DNA. We did not perform a DNase digestion step and priming of cDNA synthesis with a 3Ј-oligo(dT) PCR anchor primer, as suggested by Sallie (58) . The relevance of our control experiment, however, is not abolished by these considerations, as poly(A) ϩ RNA from HBV carrier PBMC and poly(A) ϩ RNA from virions were prepared in the same manner. If present at all, DNA contaminations should be present in both RNA preparations, and this therefore cannot explain the different results of pcPCR for subgenomic mRNAs. Third, two PCR primer sets, both able to detect the three largest HBV mRNA transcripts but located about 600 bp apart from each other, did not give rise to different amounts of pcPCR products. None of these control experiments gave any evidence that pcPCR generated artifacts due to the procedures used for RNA preparation, cDNA synthesis, or pcPCR itself. Thus, the data obtained by pcPCR prove that the 0.65-, 2.1-, and 2.4-kb HBV mRNAs are present in our patients' PBMC. The data do not allow for conclusions about the origin of the C-E RNA, which may be derived from adsorbed or ingested virions or expressed by cccDNA (29) . Our data also cannot definitely prove the integrity of the HBV RNA molecules detected in PBMC, but there was no evidence that they were defective. Due to the RNA purification procedure, a poly(A) tail must have been present at the 3Ј ends of these molecules, and at least the regions spanned by the different primer sets used for pcPCR, which together cover about 20% of the HBV genome, were amplified with a normal product size.
Transcription of HBV genes in nonhepatocytes has already been studied in transgenic mice and by vitro transfection, but these data do not represent the situation in a human HBV carrier, because additional heterologous promoters or enhancers were used or transcription came from integrated DNA (2, 15, 16, 18, 30, 41, 66) . In contrast, our findings show that HBV genes are transcribed in PBMC in vivo. The detection of significant amounts of X mRNA in the PBMC or B cells is remarkable. Only small or undetectable amounts of X mRNA have been observed in liver samples from woodchuck hepatitis virus-infected woodchucks or HBV-infected chimpanzees (40, 65) . This observation suggests that certain effects described for X-transfected cells may indeed occur in vivo, e.g., induction of HLA antigens (26) or intracellular adhesion molecule I (27) . In cell culture, X mRNA may be dispensable for hepadnavirus production, but X-deficient woodchuck hepatitis virus genomes are not viable in woodchucks (9, 68) . Besides X mRNA, larger HBV mRNAs could also be unequivocally detected in PBMC or B cells. Our data are particularly relevant for the in vivo situation because the PBMC were not stimulated by artificial reagents but were analyzed in the state in which they were obtained from circulation. It is known that transcription under the control of the C-E and pre-S promoters is highly liver specific, whereas the S and X promoters are ubiquitously active (1, 60) . Thus, the comparatively smaller amounts of C-E and pre-S RNA are in accordance with the in vitro studies on promoter specificity.
The question of whether HBV replication or at least gene expression takes place in nonhepatocytes has been discussed in numerous reports, without a general agreement. Recently, serious doubts on the biological activity of HBV genes in PBMC were raised by the application of a new PCR approach to discriminate between rcDNA present in HBV particles and cccDNA of HBV, which can be generated only in the nucleus of an infected host cell (29) . Our data support the contrary conclusion, as we were able to detect HBV mRNA sequences as well as cccDNA in PBMC from our patients. A possible explanation for the conflicting results may be the different methodological approaches used. Köck et al. (29) did not use a nested PCR primer set to detect HBV cccDNA, and they did not treat the samples with mung bean nuclease before the assay. Their PCR assay for discrimination between HBV rcDNA and cccDNA was based only on dependence of the amplification on the kind of template present if the PCR primers span the nick within the minus strand of HBV rcDNA, similar to our primers P23 to P26 (Fig. 1) . In such an approach, DNA synthesis will stop at the 3Ј end of each template strand before reaching the binding site of the opposite primer. Linear amplification of two incomplete DNA strands will result, as is visible in lane VϪ of Fig. 5C . Exponential DNA amplification will take place only after reannealing of both incompletely synthesized DNA strands. If the template concentration is kept low, reannealing of both PCR strands will rarely happen. A significantly different PCR amplication efficacy will result according to what kind of template is present, i.e., rcDNA or cccDNA. This approach, however, bears two fundamental limitations as shown by Köck et al. (29) . The amount of template added to the PCR mixture is critical. If it exceeds 10 5 genomes per 100 l of PCR mixture, discrimination between rcDNA and cccDNA is gradually lost. If it is lower than 10 3 genomes per PCR set, the sensitivity of the assay might be too low to detect the HBV sequences. Due to the relatively small range of possible template concentrations, the assay is probably not able to detect cccDNA if the ratio of rcDNA to cccDNA clearly exceeds 10 2 . The control experiments that we performed with purified virions showed that the experimental approaches we used to detect cccDNA and mRNA of HBV in PBMC were not affected by the presence of a large excess of adsorbed or phagocytosed virions.
Apart from these methodological aspects, there may be two biological reasons why HBV-specific mRNA and cccDNA were detected in PBMC from our patients but not in the study of Köck et al. (29) . As stated by those authors, the amount of PBMC-associated HBV DNA directly correlated with the virion titer in the patient's serum. Uptake of HBV and HBV gene expression by PBMC are probably a very inefficient process. Thus, the chance of detecting HBV mRNA and cccDNA should increase if the number of virions binding to the cell surface is higher (29) . The patients in our study had very high titers, more than 10 9 HBV genomes/ml of serum (51) . Unfortunately, Köck et al. (29) did not report the virion titers in their patients' sera. Even more important may be that none of our patients had any signs of a cellular immune reaction against HBV-infected liver cells. Liver biopsies revealed a normal histology or at most a minimal hepatitis with some ground-glass hepatocytes, despite the presence of hepatitis B surface antigen and core antigen in 50 to 90% of hepatocytes. There were no significant elevations of liver enzymes or any other signs of liver cell dysfunction during a period of more than 5 years when the patients had already been monitored carefully (52) . The absence of a cytotoxic immune response against HBVinfected cells may be an important prerequisite for the accumulation of infected nonhepatocytes. PBMC would most likely present T-cell epitopes of HBV much more efficiently than noninflammatory liver cells, which express very small amounts of HLA class I molecules (4) . HBV-reactive cytotoxic T cells would either destroy such cells or suppress HBV gene expression (17) .
In summary, pcPCR might be a useful tool to study HBV gene expression in PBMC and other nonhepatocytes which contain small amounts of HBV-specific nucleic acids. The assay system described in this paper provides information about the presence or absence of the different HBV transcripts in a sample. In addition, it enables a clear distinction between adherent or phagocytosed virions and intracellular HBV gene expression. Our findings with PBMC suggest that these cells are able to express mRNAs of HBV in vivo, and therefore, they might be able to generate small amounts of progeny virus.
